Features Archives - Page 5 of 15

Features

NBE Therapeutics secures new investor

Danish investor Novo Holdings is investing 20 million Swiss francs in NBE Therapeutics in a series B financing round. The Basel-based biotechnology company develops novel…

clement02.07.2018

Features

Where the life sciences are concentrated

As one of the world’s leading locations for life sciences, the Basel region is home to a cluster of companies and organizations that not only…

clement26.06.2018

Features

A quest to drug the undruggable

Undruggable - The latest Stereo Chemistry episode explores why certain drug targets are so vexing, and the cutting edge approaches chemists are taking to finally…

clement22.06.2018

Features

Roche bags full control of Foundation Medicine in $2.4B follow-up buyout

clement19.06.2018

Features

Does Theranos mark the peak of the Silicon Valley bubble?

John Carreyrou talks to Nautilus about the lessons of a $1 billion fraud. BY MICHAEL SEGALMAY 31, 2018 Silicon Valley has a term for startups…

clement31.05.2018

Features

From Rock DJ to Scientist to Entrepreneur: Michael Gilman on The Long Run Podcast

Currently (2018) Michael Gilman is the CEO of two biotech startups – Arrakis Therapeutics, a company attempting to make small molecule drugs against RNA targets;…

clement30.05.2018

Features

Novartis receives U.S. approval for migraine medication

Basel-based pharmaceutical company Novartis has received approval in the USA for its Aimovig migraine medication, developed with its partner, Amgen. It is a new therapeutic…

clement22.05.2018

Features

Basel, a hotspot for biotech and pharma according to Labiotech.eu

Basel is among the European biotech hubs with the most exciting companies as named by labiotech.eu. The industry platform highlighted businesses including Actelion, CRISPR Therapeutics…

clement18.05.2018

Features

Biotech industry continues to grow

The Swiss biotech industry continued to grow in 2017. Reaching record figures in sales and capital investments in companies, according to a new report. New…

clement14.05.2018

Features

Another Trophy Quarter For VC-Backed Biotech Funding

clement30.04.2018

Features

NBE Therapeutics secures new investor

Where the life sciences are concentrated

A quest to drug the undruggable

Roche bags full control of Foundation Medicine in $2.4B follow-up buyout

Does Theranos mark the peak of the Silicon Valley bubble?

From Rock DJ to Scientist to Entrepreneur: Michael Gilman on The Long Run Podcast

Novartis receives U.S. approval for migraine medication

Basel, a hotspot for biotech and pharma according to Labiotech.eu

Biotech industry continues to grow

Another Trophy Quarter For VC-Backed Biotech Funding

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us